I agree with henriette on this point. There isn't much choice of which pot to stir in any case, since oxycodone is now the only pot on the boil.
I would only ask that the company do the basic research on a priority basis, so as to avoid another fiasco moving from the oxycodone "research patch" to the oxycodone "commercial patch".
POH Price at posting:
2.2¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)